Children<12 months of age hospitalized with bronchiolitis
Showing 1 - 25 of >10,000
Pneumococcal Vaccines, Immunization Coverage Trial (Enhanced reminders, Standard CANImmunize notifications)
Not yet recruiting
- Pneumococcal Vaccines
- Immunization Coverage
- Enhanced reminders
- Standard CANImmunize notifications
- (no location specified)
Aug 14, 2023
Cobalamin Supply and Metabolism in Healthy Children From Birth
Not yet recruiting
- Vitamin B 12 Deficiency
-
Bregenz, Austria
- +1 more
Jun 1, 2022
Hospitalized Children With Suspected or Confirmed Nosocomial Pneumonia Trial in China, Taiwan (Ceftazidime-avibactam)
Terminated
- Hospitalized Children With Suspected or Confirmed Nosocomial Pneumonia
-
Wuxi, Jiangsu, China
- +3 more
Mar 25, 2022
PCV13 Impact on Pneumococcal Nasopharyngeal Carriage Study
Recruiting
- Community-acquired Pneumonia
- Nasopharyngeal swab
-
Quezon City, National Capital Region, PhilippinesPhilippine Children's Medical Center
Feb 14, 2022
Respiratory Syncytial Virus Infections Trial in Baltimore, Laurel (RSV ?NS2 ?1313 I1314L Vaccine, Placebo)
Recruiting
- Respiratory Syncytial Virus Infections
- RSV ΔNS2 Δ1313 I1314L Vaccine
- Placebo
-
Baltimore, Maryland
- +1 more
Dec 2, 2022
Bronchiolitis, Viral Trial in Verona (Curosurf 80Mg/Ml Intratracheal Suspension, Ambient Air)
Terminated
- Bronchiolitis, Viral
- Curosurf 80Mg/Ml Intratracheal Suspension
- Ambient Air
-
Verona, ItalyAzienda Ospedaliera Universitaria Integrata Verona
Apr 12, 2021
Typhoid Trial in Blantyre (Vi-Typhoid Conjugate Vaccine (Vi-TCV), Meningococcal A Conjugate Vaccine (MCV-A))
Active, not recruiting
- Typhoid
- Vi-Typhoid Conjugate Vaccine (Vi-TCV)
- Meningococcal A Conjugate Vaccine (MCV-A)
-
Blantyre, MalawiMalawi Liverpool Wellcome Trust Clinical Research Programme, Que
Feb 15, 2022
Quality of Life of Infants With Bronchiolitis Episodes
Completed
- Bronchiolitis
- Survey
-
Amiens, France
- +10 more
Jun 7, 2021
Human Metapneumovirus and Human Parainfluenza Infection Trial in United States (mRNA-1653, Placebo)
Completed
- Human Metapneumovirus and Human Parainfluenza Infection
- mRNA-1653
- Placebo
-
Birmingham, Alabama
- +18 more
Feb 2, 2023
RSV Infection Trial in Baltimore (RSV 6120/?NS2/1030s, Placebo)
Completed
- RSV Infection
- RSV 6120/∆NS2/1030s
- Placebo
-
Baltimore, MarylandCenter for Immunization Research, Johns Hopkins Bloomberg School
Jan 19, 2022
RSV Infection Trial in Baltimore (RSV 6120/?NS1, RSV 6120/F1/G2/?NS1, Placebo)
Active, not recruiting
- RSV Infection
- RSV 6120/∆NS1
- +2 more
-
Baltimore, MarylandJohns Hopkins University Center for Immunization Research
Feb 8, 2022
Gram-negative Bacterial Infections, Bloodstream Infections (BSI), Complicated Intra-abdominal Infection (cIAI) Trial in
Recruiting
- Gram-negative Bacterial Infections
- +6 more
- Cefiderocol
- Standard of Care
-
Brussels, Belgium
- +22 more
Jan 16, 2023
Bronchiolitis Trial in Little Rock, Omaha (Dexamethasone Oral)
Not yet recruiting
- Bronchiolitis
- Dexamethasone Oral
-
Little Rock, Arkansas
- +1 more
Aug 8, 2023
Gram-negative Bacterial Infections, Hospital Acquired Bacterial Pneumonia (HABP), Complicated Urinary Tract Infection (cUTI)
Recruiting
- Gram-negative Bacterial Infections
- +3 more
- Cefiderocol
- Standard of Care
-
Fort Worth, Texas
- +21 more
Sep 23, 2022
Mortality, Vaccines Trial in Bissau (Providing measles vaccine for all children 9-35 months who have not yet received a routine
Completed
- Mortality
- Vaccines
- Providing measles vaccine for all children 9-35 months who have not yet received a routine measles vaccine
-
Bissau, Guinea-BissauBandim Health Project
Apr 30, 2021
Healthy Toddlers 12-36 Months of Age With Mild Malnutrition Trial in Aurora (Enfagrow® Neuropro Toddler Nutritional Drink,
Recruiting
- Healthy Toddlers 12-36 Months of Age With Mild Malnutrition
- Enfagrow® Neuropro Toddler Nutritional Drink
- Pediasure® Grow & Gain Protein Shake for Kids
-
Aurora, ColoradoChildren's Hospital Colorado
May 9, 2022
Bronchiolitis Trial in United States (Winix 5500-2 HEPA filtration units)
Recruiting
- Bronchiolitis
- Winix 5500-2 HEPA filtration units
-
Anchorage, Alaska
- +16 more
Jan 4, 2023
COVID-19 Trial in United States (Biological/Vaccine: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period), SARS-CoV-2
Recruiting
- COVID-19
- Biological/Vaccine: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
- +3 more
-
Little Rock, Arkansas
- +24 more
Aug 2, 2022
Investigate Effects ofNew Infant Formula on Growth and Body
Completed
- Healthy
-
Singapore, Singapore
- +1 more
Oct 14, 2021
Pneumococcal Vaccines Trial in United States (0.5 ml dose of 1.1 mcg VAX-24, 0.5 ml dose of PCV15, 0.5 ml dose of 2.2 mcg
Recruiting
- Pneumococcal Vaccines
- 0.5 ml dose of 1.1 mcg VAX-24
- +3 more
-
Jonesboro, Arkansas
- +25 more
May 4, 2023
Meningitis, Meningococcal Trial in Bamako (Non-adjuvanted study formulation NmCV-5, Adjuvanted study formulation NmCV-5,
Completed
- Meningitis, Meningococcal
- Non-adjuvanted study formulation NmCV-5
- +2 more
-
Bamako, MaliCentre pour le Développement des Vaccins du Mali, ex-Institut Ma
Aug 10, 2021
Atopic Dermatitis Trial in Germany, United States (Pimecrolimus, Topical corticosteroids)
Completed
- Atopic Dermatitis
- Pimecrolimus
- Topical corticosteroids
-
Phoenix, Arizona
- +30 more
Feb 4, 2022
Respiratory Syncytial Virus, Bronchiolitis Trial in Saint Louis (Oral azithromycin, Placebo)
Completed
- Respiratory Syncytial Virus, Bronchiolitis
- Oral azithromycin
- Placebo
-
Saint Louis, MissouriDepartment of Pediatrics, Washington University School of Medici
Jun 6, 2022
Bronchiolitis Trial in Sohag (Vitamin D3)
Recruiting
- Bronchiolitis
- Vitamin D3
-
Sohag, EgyptSohag University Hospital
Apr 1, 2023